跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INCRUSE ELLIPTA INHALATION POWDER, PRE-DISPENSED 62.5MCG - PPB Drug Approval Details
Approvals
/
PPB
/
INCRUSE ELLIPTA INHALATION POWDER, PRE-DISPENSED 62.5MCG
Approved
STANDARD
INCRUSE ELLIPTA INHALATION POWDER, PRE-DISPENSED 62.5MCG
GLAXOSMITHKLINE LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
2713b8a03c5a0fff
Company
GLAXOSMITHKLINE LIMITED
Type
Standard
Approval Details
Approval Id
2713b8a03c5a0fff
Product Name
INCRUSE ELLIPTA INHALATION POWDER, PRE-DISPENSED 62.5MCG
Drug Hk Name
INCRUSE ELLIPTA INHALATION POWDER, PRE-DISPENSED 62.5MCG
Registration Code
HK-63954
Company Name
GLAXOSMITHKLINE LIMITED
Company Detail Path
/organization/glaxosmithkline
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2015-09-08
Company Address
FLAT/RM 04-10, 10/F, TOWER 6, THE GATEWAY, 9 CANTON ROAD, TSIM SHA TSUI, KOWLOON
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
2713b8a03c5a0fff
Type
Standard
Back to PPB Approvals